New Way to Target Hormone Receptor Thwarts Prostate Cancer

摘要

For the unlucky 10% of men diagnosed with prostate cancer who have the most aggressive form, the prognosis is grim. The available prostate cancer drugs may initially shrink their tumors, but the remaining cancer cells usually grow out of control again after a couple of years. These drug-resistant cases account for nearly 29,000 annual deaths in the United States from prostate cancer.rnResearchers led by Charles Sawyers at Memorial Sloan-Kettering Cancer Center in New York City have now developed a compound that could prevent some of the deaths.